This is a working overview of counterion, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-04-26 and is reviewed periodically as new material appears.
Regulatory status varies by country and is not harmonized. Epitalon is not an approved drug in major Western jurisdictions. In some countries it is sold as a research chemical, and in others it has appeared in products marketed for other categories. This inconsistent status means that purity, labeling accuracy, and documentation differ widely between suppliers, and verification of identity and purity through independent analysis is the usual way buyers assess a given lot.
Epitalon appears in the literature primarily through a small number of research groups, most of them associated with the St. Petersburg Institute of Bioregulation and Gerontology. Publications describe cell culture experiments, animal studies, and a limited number of small human studies. Independent replication outside this network is sparse. As a result, reviews of the topic usually separate descriptive reports of observed effects from the question of whether those effects generalize, and they note the difficulty of comparing studies that use different preparations and endpoints.
Analytical characterization of epitalon relies on standard peptide methods. Reverse-phase high-performance liquid chromatography is used to assess purity, and mass spectrometry confirms identity by checking the observed mass against the expected value near 390 daltons. Amino acid analysis can verify composition. Because the peptide is short and hydrophilic, it elutes early on many reverse-phase columns, so method development often requires ion-pairing reagents to achieve adequate retention and resolution from related impurities.
The peptide is a synthetic analogue of epithalamin, a preparation extracted from bovine pineal glands. Investigators sought a short, chemically defined molecule that would reproduce some of the endocrine and gerontological observations attributed to the glandular extract. Proposed mechanisms centre on induction of telomerase activity, an effect reported in cultured human somatic cells in the early 2000s, together with influences on melatonin secretion and neuroendocrine regulation. Those mechanisms remain incompletely characterised, and the reported telomerase response has not been consistently reproduced by independent groups working in comparable systems.
Published work on this compound consists mainly of in vitro experiments, animal studies, and small clinical investigations, a substantial share of which appeared in Russian-language journals. Sample sizes are generally small, control conditions differ between studies, and several endpoints rely on markers whose clinical meaning is itself debated. Reviews of the longevity field treat the peptide as an early example of telomerase-directed research rather than an established intervention. Regulatory treatment varies by country: some jurisdictions place it under prescription controls, others treat it as a laboratory material, and importation may be restricted regardless of local status.
Epitalon is a synthetic tetrapeptide whose sequence is alanine–glutamate–aspartate–glycine, commonly abbreviated AEDG. It was developed in Russia during the 1980s and 1990s by investigators associated with the St. Petersburg Institute of Bioregulation and Gerontology, who studied short peptides as regulators of gene expression and tissue function. The alternative spelling epithalon appears interchangeably in the literature, and the two names refer to the same molecule. Outside Russia it is encountered chiefly as a research chemical rather than a licensed medicine, and it holds no approval from the United States Food and Drug Administration or the European Medicines Agency.
| Property | Value | Notes |
|---|---|---|
| Purity assessment | RP-HPLC | Reported as percent area, often ≥95% |
| Identity confirmation | Mass spectrometry | Observed mass compared with ~390 Da |
| Typical storage temperature | -20 °C or below | Lyophilized powder, desiccated |
| Reconstitution solvent | Sterile water or buffer | Acidic residues aid dissolution |
| Common synonyms | AEDG; epithalon | Spelling varies in literature |
Reference material is normally supplied as a lyophilised powder in a sealed vial. Product literature typically recommends storage at minus twenty degrees Celsius or colder, protected from light and moisture. Freeze-thaw cycling is usually avoided because repeated condensation can introduce water into the vial. Working solutions are commonly prepared fresh, aliquoted, and kept cold for short periods rather than stored at ambient temperature. Labelling the date of opening helps track how long a vial has been in use.
Solubility is high in water, phosphate-buffered saline and normal saline, a pattern that follows from the two acidic residues in the chain. The peptide dissolves poorly in non-polar solvents such as hexane or chloroform. Stock solutions are often prepared in water first and then diluted into the buffer of interest. Because the molecule is small and hydrophilic, filtration through a low-protein-binding membrane is usually straightforward, and visible particulates are uncommon in freshly made solutions.
Identity and purity are established with reversed-phase high-performance liquid chromatography and mass spectrometry. The chromatogram shows the main peak and any truncated or oxidised by-products, while the mass spectrum confirms the expected 390 dalton mass. Amino acid analysis can corroborate composition when a sample's origin is uncertain. Counterion content, particularly residual trifluoroacetate from purification, is frequently reported alongside purity because it shifts the net mass of the solid.
Epitalon is a synthetic tetrapeptide with the sequence alanine–glutamate–aspartate–glycine, commonly abbreviated AEDG. Its design traces to epithalamin, a peptide fraction prepared from bovine pineal gland extracts that researchers in Saint Petersburg began investigating in the 1970s. The compound has a molecular formula of C14H22N4O9 and a nominal molecular mass near 390 daltons. It holds no approved drug status in the United States or the European Union, and material sold under this name is generally offered as a research chemical rather than a finished pharmaceutical product.
Proposed mechanisms centre on cell-culture observations rather than a defined receptor interaction. Several reports describe increased expression of the telomerase catalytic subunit after exposure of cultured human cells, and the authors attributed the effect to short peptide fragments entering the nucleus and influencing gene transcription. No receptor for the tetrapeptide has been identified, and the free peptide is expected to be degraded rapidly by plasma peptidases. Whether any measurable fraction reaches intact tissues after administration remains an unresolved question rather than an established finding.
The published literature is dominated by a small number of research groups, much of it in Russian-language journals, and independent replication outside those groups is limited. Studies are typically small, use cultured cells or rodent models, and report endpoints that differ between papers, which makes comparison difficult. Large randomised human trials have not appeared in the indexed literature. Questions about absorption, distribution and clearance are therefore still treated as open in reviews that mention the compound.
Low Risk: less than 1.0 mg/L Average risk: 1.0 to 3.0 mg/L High risk: above 3.0 mg/L But hs-CRP is not to be used alone and should be combined with elevated levels of cholesterol, LDL-C, triglycerides, and glucose level. Smoking, hypertension and diabetes also increase the risk level of cardiovascular disease.
== International Mass Spectrometry Foundation == The major awards from the International Mass Spectrometry Foundation are the Thomson Medal Award, the Curt Brunnée Award, and the Jochen Franzen Award.
October 5–10, 1908 - The rapidly growing, global industry and scientific quest for absolute zero led to the 1st International Congress of Refrigeration held in Paris, France, at the Paris-Sorbonne University, which welcomed over 5,000 participants. January 25, 1909 - From this first Congress, the International Association of Refrigeration was born, formed by delegates from 35 countries. June 21, 1920 - The association was reorganised and officially titled as the International Institute of Refrigeration – IIR (Institut International du Froid – IIF, in French). IIR's status as an international organisation was defined by an International Agreement signed on December 1, 1954, and General Regulations for the Application of the International Agreements signed on November 20, 1956. Since then, the IIR has been operating at its headquarters based in Paris and is now an international organisation for expertise on refrigeration. The institute has continued to run the International Congress of Refrigeration every four years since its inauguration and has now expanded its event portfolio to ten conference series covering a wide variety of refrigeration topics. Working alongside governments, today the IIR remains committed to promoting knowledge on refrigeration for sustainable development, and continues to provide key services to disseminate information on associated technologies to all stakeholders (companies, universities, professionals, etc.).
27 The Northern Alliance was outnumbered, outgunned, and undersupplied. It controlled only about 15 percent of Afghanistan. Senior U.S. commanders hoped at best that the Green Berets would boost Northern Alliance morale and help prevent the better-equipped Taliban forces from a further offensive until larger American forces could arrive. During the night of 18–19 October 2001, Operational Detachment Alpha (ODA) 595, a 12-man Green Beret team, plus two Air Force Combat Controllers, were airlifted from Karshi-Khanabad Air Base in Uzbekistan more than 300 kilometers (190 mi) across the 16,000 feet (4,900 m) Hindu Kush mountains in zero-visibility conditions. They rode aboard two SOAR MH-47E Chinook helicopters and were escorted by two MH-60L DAPs (Direct Action Penetrators). The Chinooks were refueled in-flight three times during the 11-hour mission, establishing a new world record for combat rotorcraft missions at the time. They linked up with the CIA and the Northern Alliance. They were greeted by CIA paramilitary officers from the Special Activities Division who had arrived only 10 days before. At about the same time, ODA 555 landed hundreds of miles south in the Panjshir Valley, and linked up with another Northern Alliance force. Within a few weeks the Northern Alliance, with assistance from the U.S. ground and air forces, captured several key cities from the Taliban.
Sources: en.wikipedia.org
The lower the barrier and the masses of the fragments, the greater the probability per unit time of a split. Protons in a nucleus are bound together by the strong force, which counterbalances the Coulomb repulsion between positively charged protons. In heavier nuclei, larger numbers of uncharged neutrons are needed to reduce repulsion and confer additional stability. Even so, as physicists started to synthesize elements that are not found in nature, they found the stability decreased as the nuclei became heavier. Thus, they speculated that the periodic table might come to an end. The discoverers of plutonium (element 94) considered naming it "ultimium", thinking it was the last. Following the discoveries of heavier elements, of which some decayed in microseconds, it then seemed that instability with respect to spontaneous fission would limit the existence of heavier elements. In 1939, an upper limit of potential element synthesis was estimated around element 104, and following the first discoveries of transactinide elements in the early 1960s, this upper limit prediction was extended to element 108.
Together, the Barshop Institute's diverse portfolio of clinical trials provides a unique environment in which discoveries made in the laboratory can be translated into interventions with the potential to transform the prevention and treatment of age-related diseases. By combining internationally recognized expertise in basic biology, translational science, clinical investigation, and population health, the Institute is advancing a new paradigm of medicine that seeks not only to extend lifespan, but to maximize healthspan, resilience, and independence throughout the aging process.
1911: Polish-born physicist and chemist Marie Curie became the first woman to receive the Nobel Prize in Chemistry, which she received "[for] the discovery of the elements radium and polonium, by the isolation of radium and the study of the nature and compounds of this remarkable element". This made her the first person to win the Nobel Prize twice. As of 2022, she is the only woman to win it twice and the only person to win the Nobel Prize in two scientific fields. 1911: Norwegian biologist Kristine Bonnevie became the first woman member of the Norwegian Academy of Science and Letters. 1912: American astronomer Henrietta Swan Leavitt studied the bright-dim cycle periods of Cepheid stars, then found a way to calculate the distance from such stars to Earth. 1912: Canadian botanist and geneticist Carrie Derick was appointed a professor of morphological botany at McGill University. She was the first woman to become a full professor in any department at a Canadian university. 1912: Bengali physician Jamini Sen became the first female Fellow of the Royal Faculty of Physicians and Surgeons of Glasgow. 1913: Regina Fleszarowa became the first Polish woman to receive a PhD in natural sciences. 1913: Izabela Textorisová, the first Slovak female botanist, published "Flora Data from the County of Turiec" in the journal Botanikai Közlemények. Her work uncovered more than 100 previously unknown species of plants from the Turiec area.
Sources: en.wikipedia.org
Identity is normally confirmed by mass spectrometry, which checks the measured mass against the expected value near 390 daltons. Reverse-phase high-performance liquid chromatography is used alongside it to assess purity. Amino acid analysis can provide additional composition data.
The powder is generally kept refrigerated or frozen, protected from light and moisture. Vials should reach room temperature before opening to prevent condensation. Reconstituted solutions are usually stored cold and used within a limited window because dilute solutions can degrade or support microbial growth.
Epitalon is not an approved drug in major Western regulatory jurisdictions. Its legal status differs between countries, and it is often distributed as a research chemical. This means product documentation and purity vary considerably between suppliers.
Epitalon is a synthetic four-amino-acid peptide with the sequence alanine–glutamate–aspartate–glycine, also written AEDG. It was developed in Russian gerontology research and is studied for proposed effects on telomerase, melatonin regulation, and neuroendocrine function. It is not an approved pharmaceutical in the United States or the European Union.